Serving Toronto, Oakville, Burlington, Mississauga, Hamilton and the GTA
|
For facial cosmetic surgery in Oakville, Ontario, south of Toronto, contact the Institute of Cosmetic & Laser Surgery. Our doctors are committed to providing superior results in a comfortable environment. |
Dr. Sapra and Dr. Khanna believe that being on the forefront of medical practice is important and dedicate part of their respective practices to medical research. The Institute of Cosmestic and Laser Surgery is actively involved in helping bring new medical therapies to the dermatology and plastic surgery fields by participating in clinical research studies.
The benefits of participating in clinical research studies for the patients include the potential access to new medical therapies, and the knowledge that you are helping the advancement of medical resuearch for mankind. Participants in clinical trials are ensured of their confidentiality, and will receive comprehensive care and attention.
For information on participating in one of our current or upcoming clinical trial studies, please contact us and speak with Dr. Sapra or Dr. Khanna.
Phase 1-2, Multicenter, Randomized, Placebo-controlled, Parallel-group Study of the Safety and Efficacy of ATX-101 (Sodium Deoxycholate for Injection) for the Reduction of Subcutaneous Fat in the Submental Area
Compassionate use of Metvix PDT in Subjects with Field Actinic Keratoses, large/multiple superficial BCCs or Bowen's Disease.
Dr. Sapra and Dr. Khanna are fully committed to research for more than eight years. Their partnerships include: MEDICIS, LEOPHARMA, Glaxo Smith Kline, Hoffmann-LaRoche Ltd., Q-Med., Amgen Canada, Omnicare, Galderma Canada, Sanofi-Aventis, Abbott and Bristol-Myers Squibb. Dr. Sapra and Dr. Khanna have experience with Phase I-II, Phase II, Phase III and Phase IV studies.
These are some of the many reasons why we should be your preferred clinical trials facility:
We want to be your research team.